gene correction

ReCode Therapeutics Announces Scientific Advisory Board, New Scientific Adviser

by | Nov 18, 2022
The advisers will work closely with management to support ReCode's expansion of its targeted-delivery genetics medicines platform and advance its pipeline of mRNA and gene correction therapeutics.
MORE
Protecting your privacy. We have strengthened our Privacy Policy to better protect you. This Policy includes our use of cookies to give you the best online experience and provide functionality essential to our services. By clicking ‘I Accept’ or by continuing to use our website, you are consenting to our Privacy Policy.